observations between ourselves and Dr Kay and his colleagues may be explicable by differences in the route of administration of monocrotaline and the size of the animals used. (ii) We find lung hyperplasia, right ventricular hypertrophy, and reductions in serotonin transport in the absence of changes in lung total ACE. (iii) If hyperplasia of an organ occurs, the expression of enzyme activities on a total organ basis is appropriate. (iv) We have observed right ventricular hypertrophy only after the development of lung hyperplasia. It is implied by Drs Keane and Kay that right ventricular hypertrophy may be obtained after monocrotaline administration in the absence of lung hyperplasia. This is an important statement, and should be appropriately documented (no data on organ weights are presented in their report), as it has a bearing on hypotheses concerning the inducement of hypertrophy. A 22 year old woman developed bilateral pleural effusions one month after classical repair of severe asymmetrical pectus excavatum. She also presented with clinical features of a right calf vein thrombosis. She was anticoagulated with heparin, but sustained a cardiorespiratory arrest 45 days after operation and was thought to have sustained a massive pulmonary embolism. When the chest was opened, however, the pericardium was found to contain a tense collection of pus. This was drained, with immediate improvement in the circulation. Her subsequent postoperative course was uneventful.
Occasional reports of purulent pericarditis following oesophageal perforation have appeared' and on one occasion this presented as pericardial tamponade.2 Purulent pericarditis rarely occurs after surgery when the pericardium is not opened3 and to our knowledge this is the first report of pyogenic tamponade complicating repair of pectus excavatum.
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